Last reviewed · How we verify
Leukoreduced blood components
Leukoreduced blood components is a Biologic drug developed by University of Washington. It is currently FDA-approved.
Leukoreduced blood components are used to treat conditions such as iron deficiency, transfusion-related complications, and liver transplant, as well as to study the in-vivo performance of blood component transfusion. Leukoreduced blood components are collected using systems like the Trima Accel, which uses non-DEHP disposable sets, and are stored for up to 42 days.
At a glance
| Generic name | Leukoreduced blood components |
|---|---|
| Sponsor | University of Washington |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Trima Non-DEHP Leukoreduced Red Blood Cell In Vivo Recovery Study (NA)
- Whole Blood in Trauma Patients With Hemorrhagic Shock (PHASE3)
- An In Vivo 24-Hour Recovery Study of Whole Blood by the Reveos System (NA)
- Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality (NA)
- Cold Stored Whole Blood in Cardiothoracic Surgery (NA)
- Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation (EARLY_PHASE1)
- Impact of the Preparation Method of Red Cell Concentrates on Transfusion Indices in Thalassemic Patients (PHASE4)
- POOLED Red Blood Cells Prepared From Pooling 5 Leukoreduced, Irradiated RBC Units (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Leukoreduced blood components CI brief — competitive landscape report
- Leukoreduced blood components updates RSS · CI watch RSS
- University of Washington portfolio CI
Frequently asked questions about Leukoreduced blood components
What is Leukoreduced blood components?
Who makes Leukoreduced blood components?
What development phase is Leukoreduced blood components in?
Related
- Manufacturer: University of Washington — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing